1-(Bromomethyl)-4-chlorobenzene → 5-tert-Butyl-3-(4-chloro-benzyl)-7-(3,3-difluoro-pyrrolidin-1-yl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine

HRID 400857

Reaktionsgleichung

Reaktionsgleichung von HRID 400857
[C:1]([C:5]1[N:6]=[C:7]([N:16]2[CH2:20][CH2:19][C:18]([F:22])([F:21])[CH2:17]2)[C:8]2[N:13]=[N:12][N:11]([CH2:14][CH3:15])[C:9]=2[N:10]=1)([CH3:4])([CH3:3])[CH3:2].C(C1N=C(N2CCC(F)(F)C2)C2N=NNC=2N=1)(C)(C)C.BrCC1[CH:50]=[CH:49][C:48]([Cl:51])=[CH:47][CH:46]=1>>[C:1]([C:5]1[N:6]=[C:7]([N:16]2[CH2:20][CH2:19][C:18]([F:21])([F:22])[CH2:17]2)[C:8]2[N:13]=[N:12][N:11]([CH2:14][C:15]3[CH:50]=[CH:49][C:48]([Cl:51])=[CH:47][CH:46]=3)[C:9]=2[N:10]=1)([CH3:2])([CH3:3])[CH3:4]

Komponenten

4

Versuchsvorschrift

In analogy to the procedure described for the synthesis of 5-tert-butyl-7-(3,3-difluoro-pyrrolidin-1-yl)-3-ethyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine (example 61), the title compound was prepared from 5-tert-butyl-7-(3,3-difluoropyrrolidin-1-yl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine and 1-(bromomethyl)-4-chlorobenzene and isolated as white solid (5.8 mg, 35%). MS (m/e): 407.4 (MH+).

Quellen und Nachweise

ORD-Eintrag
ord-9202960b73aa47bcadd6c1cf18817887
Quelldatensatz
uspto-grants-2014_06
Patentnummer
US08741906B2

Verknüpfte Notizen

Wird geladen…